Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Operating Expenses (2016)

Historic Other Operating Expenses for Tenax Therapeutics (TENX) over the last 5 years, with Q4 2016 value amounting to $33.3 million.

  • Tenax Therapeutics' Other Operating Expenses changed N/A to $33.3 million in Q4 2016 from the same period last year, while for Sep 2017 it was $33.3 million, marking a year-over-year change of. This contributed to the annual value of $33.3 million for FY2016, which is N/A changed from last year.
  • Per Tenax Therapeutics' latest filing, its Other Operating Expenses stood at $33.3 million for Q4 2016.
  • In the past 5 years, Tenax Therapeutics' Other Operating Expenses ranged from a high of $33.3 million in Q4 2016 and a low of $363691.0 during Q2 2012
  • Over the past 4 years, Tenax Therapeutics' median Other Operating Expenses value was $712916.5 (recorded in 2013), while the average stood at $8.8 million.
  • As far as peak fluctuations go, Tenax Therapeutics' Other Operating Expenses soared by 2040.99% in 2012, and later soared by 750.06% in 2013.
  • Quarter analysis of 4 years shows Tenax Therapeutics' Other Operating Expenses stood at $363691.0 in 2012, then rose by 7.5% to $390970.0 in 2013, then surged by 164.69% to $1.0 million in 2015, then surged by 3114.44% to $33.3 million in 2016.
  • Its last three reported values are $33.3 million in Q4 2016, $1.0 million for Q2 2015, and $390970.0 during Q2 2013.